跳至主要内容
临床试验/ISRCTN95953457
ISRCTN95953457已完成不适用

The effect of herbal extract (EstroG-100) on pre-, peri- and post-menopausal women: a randomised double-blind placebo-controlled study

aturalendo Tech Co., Ltd (South Korea)0 个研究点目标入组 64 人开始时间: 2010年10月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Women aged between 42 and 70 years
  • 2. Moderate or severe menopausal symptoms (score of greater than or equal to 20) identified by a simplified questionnaire with the Kupperman Menopause Index (KMI)
  • 3. Eligibility was re-examined with the results of laboratory, mammogram, and pelvic ultrasound tests

排除标准

  • 1. Concurrent use of dietary supplement for menopause symptoms
  • 2. Any suspicion of breast or endometrial malignancy
  • 3. History of using oestrogen or progestin-containing products in past 3 months
  • 4. Psychoactive drugs
  • 5. Body mass index (BMI) greater than 40 kg/m^2
  • 6. Irregular gynaecological bleeding 1 year after menopause
  • 7. Hysterectomy
  • 8. Uncontrolled hypertension
  • 9. Thyroid disease
  • 10. Diabetes mellitus
  • 11. History of hormone-dependent (gynaecological) cancer
  • 12. Drug and alcohol abuse
  • 13. Mental disorder
  • 14. Abnormality in renal and liver functions
  • 15. Personal or family history of breast cancer in first degree relative
  • 16. History of clotting disorder such as deep vein thrombosis (DVT)

研究者

发起方
aturalendo Tech Co., Ltd (South Korea)

相似试验